Conyers Park III Acquisition Corp. (CPAAU)
Price:
10.26 USD
( + 0.02 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Agriculture & Natural Solutions Acquisition Corporation
VALUE SCORE:
6
2nd position
Melar Acquisition Corp. I
VALUE SCORE:
11
The best
M3-Brigade Acquisition V Corp. Units
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Conyers Park III Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on the consumer sector and consumer-related businesses. The company was incorporated in 2021 and is based in Naples, Florida.
NEWS

U.S. IPO Weekly Recap: Summer's Last Wave With 2 IPOs
seekingalpha.com
2021-08-13 20:10:00The summer IPO market is wrapping up, and while we could see a few more launches, this past week's two deals should be some of the last IPOs before fall. SPAC activity continued to bounce back, with 17 blank check IPOs during the week.

Conyers Park III Acquisition Corp. Announces Closing of $350 Million Initial Public Offering
prnewswire.com
2021-08-12 16:43:00NAPLES, Fla., Aug. 12, 2021 /PRNewswire/ -- Conyers Park III Acquisition Corp. (NASDAQ: CPAAU) (the "Company"), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, today announced the closing of its initial public offering of 35,000,000 units at a price of $10.00 per share.

U.S. IPO Weekly Recap: Micro Caps Lead A Quiet 2 IPO Week
seekingalpha.com
2021-07-09 22:25:00After a record breaking number of deals last week, the IPO market cooled off for the shortened holiday week, with just two micro-cap IPOs raising $45 million. Preclinical RNA biotech Transcode Therapeutics priced at $4 to raise $25 million at a $54 million market cap.

Alpha Trader Podcast: Talking SPACs With Chris DeMuth; Talking Markets And Gold With Lyn Alden Schwartzer
seekingalpha.com
2020-07-28 08:00:00This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher speaking with Lyn Alden Schwartzer and Chris DeMuth.

Conyers Park II Acquisition: 4-5x Upside For SPAC Warrants
seekingalpha.com
2020-07-13 12:00:00Conyers Park II is one of the best available SPACs. Their warrants offer leverage on a successful deal.

10 SPAC IPO Stocks to Buy As the Market Enters Bear Territory
investorplace.com
2020-03-13 16:54:16As the markets continue further into bear-market territory, investors might want to consider some of these SPAC IPO stocks.
No data to display

U.S. IPO Weekly Recap: Summer's Last Wave With 2 IPOs
seekingalpha.com
2021-08-13 20:10:00The summer IPO market is wrapping up, and while we could see a few more launches, this past week's two deals should be some of the last IPOs before fall. SPAC activity continued to bounce back, with 17 blank check IPOs during the week.

Conyers Park III Acquisition Corp. Announces Closing of $350 Million Initial Public Offering
prnewswire.com
2021-08-12 16:43:00NAPLES, Fla., Aug. 12, 2021 /PRNewswire/ -- Conyers Park III Acquisition Corp. (NASDAQ: CPAAU) (the "Company"), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, today announced the closing of its initial public offering of 35,000,000 units at a price of $10.00 per share.

U.S. IPO Weekly Recap: Micro Caps Lead A Quiet 2 IPO Week
seekingalpha.com
2021-07-09 22:25:00After a record breaking number of deals last week, the IPO market cooled off for the shortened holiday week, with just two micro-cap IPOs raising $45 million. Preclinical RNA biotech Transcode Therapeutics priced at $4 to raise $25 million at a $54 million market cap.

Alpha Trader Podcast: Talking SPACs With Chris DeMuth; Talking Markets And Gold With Lyn Alden Schwartzer
seekingalpha.com
2020-07-28 08:00:00This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher speaking with Lyn Alden Schwartzer and Chris DeMuth.

Conyers Park II Acquisition: 4-5x Upside For SPAC Warrants
seekingalpha.com
2020-07-13 12:00:00Conyers Park II is one of the best available SPACs. Their warrants offer leverage on a successful deal.

10 SPAC IPO Stocks to Buy As the Market Enters Bear Territory
investorplace.com
2020-03-13 16:54:16As the markets continue further into bear-market territory, investors might want to consider some of these SPAC IPO stocks.